PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION OF THE FIRST-IN-CLASS SELECTIVE SIK2/SIK3 INHIBITOR GLPG3970 IN EXPERIMENTAL MODELS OF IBD

Anna Pereira-Fernandes  ¹     Stéphanie Lavazais  ²     Carole Delachaume     Michael Drennan     Didier Merciris     Nancy Agten     Christophe Peixoto     Anne Gigout     Nicolas Desroy     David AMANTINI     Steve De Vos    
¹ Galapagos NV, Mechelen, Belgium
² Galapagos SASU, Romainville, France

Topic
Disease Mechanisms, IBD, Immunology

Session
Basic science in IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)